We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Powerful Tool Detects Fast-Spreading SARS-COV-2 Variants

By LabMedica International staff writers
Posted on 30 Jan 2025
Print article
Image: The tool can detect SARS-CoV-2 variants having high transmission potential (Photo courtesy of 123RF)
Image: The tool can detect SARS-CoV-2 variants having high transmission potential (Photo courtesy of 123RF)

Throughout the course of the COVID-19 pandemic, new variants of SARS-CoV-2 have emerged, each demonstrating increased transmissibility. Viruses can mutate in ways that enhance their ability to infect hosts, either by increasing viral load or evading immune responses. Rapid detection of these mutations is crucial to understanding viral biology and identifying new variants that may require further investigation. Quickly identifying mutations that contribute to higher transmission rates can aid in outbreak control and help spot potential immune escape variants. However, determining how individual mutations influence viral transmission has proven to be a difficult task. To overcome this challenge, researchers have developed a tool capable of detecting SARS-CoV-2 variants with high transmission potential before they become widespread.

A team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute, Melbourne, Australia) and the University of Pittsburgh (Pittsburgh, PA, USA), analyzed millions of viral genome sequences from around the world. Their work revealed specific mutations that give SARS-CoV-2 a significant advantage in spreading. While many of these mutations were found in the virus’s spike protein, which is responsible for allowing the virus to enter human cells and is targeted by antibodies, the researchers also discovered important mutations in less-studied regions of the virus.

These mutations play a role in enhancing the virus's ability to bind to human cells, evade immune responses, or alter protein structure. Unlike previous methods, this new model, highlighted in Nature Communications, uses genomic surveillance data to accurately identify the mutations driving the spread of certain variants, even when these mutations appear in only a small fraction of cases. While the model was developed specifically for SARS-CoV-2, the researchers believe it can be adapted to track the transmission of other pathogens, such as influenza.

“Our method is like a magnifying glass for viral evolution, helping public health systems spot and monitor highly transmissible variants before they become widespread,” said Associate Professor John Barton from the University of Pittsburgh, co-lead author of the study. “Not only can we track SARS-CoV-2 more effectively, but our method can also be adapted to study the evolution of other pathogens, helping us stay ahead of future outbreaks. It’s a powerful tool for global efforts to tackle emerging diseases.”

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.